Priv. Doz. Dr. med. Ghazaleh Gouya Lechner
Founder of Gouya Insights
Phone: +43 650 4704206
E-Mail: gouya@gouya-insights.com

Ghazaleh Gouya is board certified in Internal Medicine, Cardiology and Clinical Pharmacology, MD, with more than 20 years of clinical research experience. After 6 years of clinical practice in internal medicine and cardiology in UK and Austria Ghazaleh Gouya joined the cardiovascular research team at the Department of Clinical Pharmacology, Medical University Vienna. During her stay at the Medical University Vienna she finalized her training in cardiology focused on heart failure disease management. In March 2015 she was awarded the title Associate Professor for Internal Medicine from the Medical University Vienna with her habilitation thesis “Efficacy and Effectiveness of Antithrombotic Therapy”.

Ghazaleh Gouya takes leadership in clinical development for strategic planning and in setting up the roadmap for the clinical development program. In December 2016 she founded Gouya Insights.

Dr. Kerstin Zoidl
Clinical Projectmanagement
Phone: +43 664 2408538
E-Mail: zoidl@gouya-insights.com

Dr. Kerstin Zoidl is an experienced molecular geneticist with expertise in cancer research and epidermal biology. Kerstin joined Gouya Insights KG as Clinical Project Manager with a view to improve the efficiency of clinical development programs driving scientific innovations into medical solutions. Acting as the sponsors representative, Kerstin directs and coordinates clinical research projects and ensures compliance with protocols and all relevant clinical and regulatory requirements.

In the Cancer and Cell Signalling Laboratory at the Institute for Molecular Bioscience in Brisbane, Kerstin studied the cellular origin of basal cell carcinomas focusing on multipotent stem cells and wound-induced cancer development. Kerstin holds an MSc in Genetics from the University of Salzburg and a PhD in Molecular Genetics from the University of Queensland and completed advanced training courses in business management and clinical monitoring.

Dr. Joana Enes
Medical Writing
Phone: +43 676 7876994

Joana earned her PhD in Neuroscience from Max-Planck Institute (Germany) in 2010 and conducted postdoctoral studies at Brandeis University in Boston (U.S.A). Altogether, she brings more than 15 years of research experience in key therapeutic areas, such as neurology, cardiology and oncology. Following her interest in Drug Discovery & Development, she later worked at a clinical research consulting firm in Boston. She moved to Austria in 2017 and joined Gouya Insights * in June 2018.

Dr. Berta Moritz
Pharmavigilance (part-time)
E-Mail: moritz@gouya-insights.com

Berta Moritz has more than 25 years of experience in the different stages of the Drug Discovery & Development process, in particular process development, clinical research/development and regulatory affairs. She worked in congenital haemostatic disorders, intensive care, pulmonology and oncology. She joins Gouya Insights KG focusing on pharmacovigilance in clinical trials. She holds a PhD in Zoology/Biochemistry from the University of Graz.

Dagmar Wagner, MSc
Quality Management
Phone: +43 676 7880981
E-Mail: wagner@gouya-insights.com

Dagmar brings more than 25 years of experience as a biomedical analyst in medical diagnostics and research. She also worked as a team leader and head of quality management in a biotech company.

In 2013 she decided to study “Coaching, Organisational and Personnel Development” at ARGE Bildungsmanagement Vienna, which she successfully completed in 2015 with a diploma. Subsequently she graduated her Master’s degree in “Consulting Sciences and Management of Social Systems” at the Sigmund Freud Private University in Vienna.

Dagmar joined Gouya Insights in February 2019 with a view to further development of quality management.

Kateryna Uspenska, PhD
Clinical Project Manager
E-Mail: uspenska@gouya-insights.com

Kateryna has a background in biochemistry, immunology, and neuroscience with a Ph.D. from the Palladin Institute of Biochemistry, Kyiv, and 8 years hands-on experience in a laboratory, including in the neurobiology laboratory at the Institut Pasteur, Paris, and at the Institute of Physiology, Tübingen.Kateryna’s scientific interests focused on neurodegenerative diseases and nicotinic addiction.

In Gouya Insights KG Kateryna acts as a liaison between the study sponsor and the clinical study team. As a clinical project manager, she is involved in planning and managing all aspects of clinical projects: from concept through study report completion. Her major priority is to ensure studies are carried out according to the study protocol and authority regulations and to offer strategic solutions to execute clinical trials successfully.

Corina Eger-Contawe, MSc
Clinical Project Manager
E-Mail: eger@gouya-insights.com

After earning her degree from the University of California at Santa Cruz in Biochemistry and Molecular Biology, Corina furthered her education in Europe at the Technical University of Vienna with a master’s degree in Biomedical Engineering. Her thesis, completed with the Austrian Institute of Technology‘s Cardiovascular Diagnostics department, focused on the development of algorithms for the analysis of electrocardiography signals.

Prior to working with Gouya Insights, Corina worked as a software engineer in various sectors including Data Analytics and Cybersecurity. Her focus now lies in the fostering of innovative solutions in the clinical drug and medical device sector as a clinical project manager.

DI Dr. Peter Lechner
Biostatistics and Datamanagement
Phone: +43 664 1317232
E-Mail: peter.lechner@lgs-insights.com

 
Peter Lechner holds a PhD in Technical Mathematics. After his academic career he worked for leading international companies in various managing positions. He gathered profound expertise in trial designs and statistical analysis including regulatory requirements as well as data management and related IT services.

In 2014 Peter Lechner founded LGS-Insights e.U. The company offers services in all phases of research and development from phase I clinical analysis to post-marketing services for a wide range of therapeutic areas. The key expertise covers the spectrum from trial design to statistical analysis and data management.